Today: 29 April 2026
Browse Category

NASDAQ:GBT 16 August 2025 - 18 August 2025

Biotech, Pharma, and Health Breakthroughs You Missed on August 17–18, 2025

Biotech, Pharma, and Health Breakthroughs You Missed on August 17–18, 2025

The FDA approved Tonix’s Tonmya as the first new fibromyalgia drug in over 15 years. Novo Nordisk’s Wegovy received accelerated FDA approval for MASH, becoming the first GLP-1 therapy cleared for the liver disease. Pfizer’s sickle cell drug inclacumab failed a Phase 3 trial, marking another setback after its $5.4 billion Global Blood Therapeutics acquisition. Eli Lilly announced a $1.3 billion AI drug partnership with Superluminal.
18 August 2025
·····
Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

Pfizer’s sickle cell drug inclacumab failed a Phase 3 trial, missing its main goal and deepening setbacks from its $5.4 billion Global Blood Therapeutics acquisition. In contrast, Pfizer and Merck’s Padcev-Keytruda combo improved survival in muscle-invasive bladder cancer. Novo Nordisk’s Wegovy won FDA approval for treating metabolic dysfunction-associated steatohepatitis.
17 August 2025
······
Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy became the first GLP-1 therapy approved by the FDA for MASH, affecting about 5% of U.S. adults. Tonix’s Tonmya was cleared for fibromyalgia, the first new therapy in 15 years. Pfizer’s inclacumab failed a key sickle cell trial, and Oxbryta was withdrawn. BioNTech agreed to acquire CureVac in a $1.25 billion all-stock deal.
16 August 2025
··········

Stock Market Today

  • Singapore Exchange Ltd (SG1S04926220): Trading Dominance Key for Global Investors
    April 29, 2026, 5:47 AM EDT. Singapore Exchange Ltd (SG1S04926220) stands out as Asia's stable financial hub, driving liquidity and listings vital for global investors, especially from the U.S. Its business model spans trading fees, clearing services, listing fees, and market data sales, creating diversified and resilient revenue streams. The derivatives market, including FTSE China A50 futures, attracts international participants, while equities listings now feature significant tech firms from China and India. SGX's time zone advantage bridges U.S. and Asian markets, providing liquidity when Western exchanges are closed. This makes SGX a strategic play for investors seeking steady income and regional growth exposure without the volatility typical of emerging markets.

Latest article

These 5 Penny Tech Stocks Are Back in Focus as AI Jitters Hit Nasdaq

These 5 Penny Tech Stocks Are Back in Focus as AI Jitters Hit Nasdaq

29 April 2026
Shares of five U.S.-listed AI penny stocks, including Fabric.AI, Kopin, Blaize, RedCloud, and U-BX Technology, traded below $5 as tech stocks wobbled ahead of major earnings. Fabric.AI announced a $21.5 million private placement and a shift to AI data center infrastructure. Kopin reported a $15 million development order from Fabric.AI. Blaize unveiled a partnership with Nokia and PT Datacomm for AI deployment in Southeast Asia.
Quantum Stocks With Growth Potential in April-May 2026: 4 Names Facing a May Reality Check

Quantum Stocks With Growth Potential in April-May 2026: 4 Names Facing a May Reality Check

29 April 2026
IonQ, Rigetti, and D-Wave will report earnings between May 6 and May 12, with investors watching revenue, bookings, and cash burn. IonQ shares last traded at $43.08, Rigetti at $16.39, D-Wave at $18.11, and Quantum Computing Inc. at $8.57, all with negative price-to-earnings ratios. IonQ announced a quantum-safe network project in Florida. The sector faces pressure from new IPOs and SPACs.
Best Stocks to Buy Today: 5 Earnings Stocks Wall Street Is Watching Before the Fed Decision

Best Stocks to Buy Today: 5 Earnings Stocks Wall Street Is Watching Before the Fed Decision

29 April 2026
Seagate shares jumped 16% in extended trading after forecasting fourth-quarter revenue above estimates and reporting strong third-quarter results. HSBC upgraded U.S. equities to “overweight” following robust earnings, with 84% of reporting companies beating Wall Street forecasts. Bloom Energy raised its 2026 outlook after posting a 130% revenue jump. Coca-Cola lifted its annual profit forecast after beating expectations.
Go toTop